MeSH D002385 - cataplexy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Avadel Pharmaceuticals | Oxybate | Lumryz | 2037-07-21 | 2023-05-01 |  |  |
| Hikma Pharmaceuticals | Oxybate | Oxybate |  | 2017-01-17 |  |  |
| Jazz Pharmaceuticals | Oxybate | Xyrem | 2022-12-17 | 2002-07-17 | $221.767 M | Q1/24-Q1/25 |
| Oxybate | Xywav | 2022-12-17 | 2020-07-21 | $1,417.042 M | Q1/24-Q1/25 | |
| UCB | Oxybate | Xyrem |  | 2005-10-13 |  |  |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
50%4/8
Approved: 4Overall Success rate: 0%
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use